Table 1 Sample descriptives
From: Indication-wide drug pricing: Insights from the pharma market
Variable | Not reference price regulated (NRP) packages | Reference price regulated (RP) packages | ||||
|---|---|---|---|---|---|---|
N | Mean [€] | Mean [%] | N | Mean [€] | Mean [%] | |
Company | 665 | 269 | ||||
Medication packs | 27,618 | 37,244 | ||||
Molecule | 2,051 | 635 | ||||
ATC level 1—indications | 14 | 14 | ||||
Manufacturer rebate | 42.80 | 0.56 | ||||
Manufacturer price | 604.84 | 112.11 | ||||
Wholesale price | 609.09 | 115.63 | ||||
Pharmacy retail price | 747.97 | 151.90 | ||||
Reference price | 0.00 | 154.40 | ||||
Co-payment | 7.79 | 5.23 | ||||
Discount agreement | 20.08 | 37.63 | ||||
No co-payment | 6.24 | 10.98 | ||||
Top 20 pharma companies | 8.62 | 4.69 | ||||
Import | 42.38 | 24.62 | ||||